AbbVie is an American publicly traded biopharmaceutical company founded in 2013.
Global 500, is an annual ranking of the top 500 corporations worldwide
Global 500AbbVie has temporarily suspended operations for the aesthetics products in Russia and paused the start of new clinical studies. Other operations are continued. Revenue increased in 2024 vs 2023 by more than +50%.
April 12, 2024 | A collapse in supplies of Western medicines has begun in Russia |
April 05, 2023 | Letter sent by B4Ukraine to the company (no response provided) |